Management of giant hemangioma of the liver: Resection versus observation

Thomas Schnelldorfer, Adam L. Ware, Rory Smoot, Cathy D. Schleck, William S. Harmsen, David M. Nagorney

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Background Management of patients with giant hemangiomas of the liver encounters persistent controversy. Although recent case series suggest a low complication rate with nonoperative management, the classic paradigm of preventive operative resection remains. Study Design A retrospective cohort study was conducted of 492 patients with giant hepatic hemangioma (>4 cm in size) diagnosed between 1985 and 2005 at Mayo Clinic Rochester. Long-term outcomes were assessed by patient survey, with a follow-up of 11 ± 6.4 years. Results Of 492 patients, 289 responded to the survey. In the nonoperative group (n = 233), 20% had persistent or new onset of hemangioma-associated symptoms, including potentially life-threatening complications in 2%. In the operative group (n = 56), perioperative complications occurred in 14%, including potentially life-threatening complications in 7%. None of the operative patients had persistent or new onset of hemangioma-associated symptoms after resection of the dominant hemangioma. In group comparison, the rate of adverse events was similar (20% versus 14%; p = 0.45) with an overall low risk for potentially life-threatening complications (2% versus 7%; p = 0.07). Size of hemangiomas was not associated with adverse events in either group. Subjective health status and quality of life at follow-up were similar in both groups (p > 0.54). Conclusions Clinical observation of patients with giant hemangioma of the liver has a similar rate of complications compared with operative management, but might prevent the need for invasive interventions in some patients. Clinical observation is preferred in most patients and operative treatment should be reserved for patients with severe symptoms or disease-associated complications.

Original languageEnglish (US)
Pages (from-to)724-730
Number of pages7
JournalJournal of the American College of Surgeons
Volume211
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Hemangioma
Observation
Liver
Diagnostic Self Evaluation
Health Status
Cohort Studies
Retrospective Studies
Quality of Life

ASJC Scopus subject areas

  • Surgery

Cite this

Schnelldorfer, T., Ware, A. L., Smoot, R., Schleck, C. D., Harmsen, W. S., & Nagorney, D. M. (2010). Management of giant hemangioma of the liver: Resection versus observation. Journal of the American College of Surgeons, 211(6), 724-730. https://doi.org/10.1016/j.jamcollsurg.2010.08.006

Management of giant hemangioma of the liver : Resection versus observation. / Schnelldorfer, Thomas; Ware, Adam L.; Smoot, Rory; Schleck, Cathy D.; Harmsen, William S.; Nagorney, David M.

In: Journal of the American College of Surgeons, Vol. 211, No. 6, 12.2010, p. 724-730.

Research output: Contribution to journalArticle

Schnelldorfer, T, Ware, AL, Smoot, R, Schleck, CD, Harmsen, WS & Nagorney, DM 2010, 'Management of giant hemangioma of the liver: Resection versus observation', Journal of the American College of Surgeons, vol. 211, no. 6, pp. 724-730. https://doi.org/10.1016/j.jamcollsurg.2010.08.006
Schnelldorfer, Thomas ; Ware, Adam L. ; Smoot, Rory ; Schleck, Cathy D. ; Harmsen, William S. ; Nagorney, David M. / Management of giant hemangioma of the liver : Resection versus observation. In: Journal of the American College of Surgeons. 2010 ; Vol. 211, No. 6. pp. 724-730.
@article{32781105ec98430f8e88179309d15bcb,
title = "Management of giant hemangioma of the liver: Resection versus observation",
abstract = "Background Management of patients with giant hemangiomas of the liver encounters persistent controversy. Although recent case series suggest a low complication rate with nonoperative management, the classic paradigm of preventive operative resection remains. Study Design A retrospective cohort study was conducted of 492 patients with giant hepatic hemangioma (>4 cm in size) diagnosed between 1985 and 2005 at Mayo Clinic Rochester. Long-term outcomes were assessed by patient survey, with a follow-up of 11 ± 6.4 years. Results Of 492 patients, 289 responded to the survey. In the nonoperative group (n = 233), 20{\%} had persistent or new onset of hemangioma-associated symptoms, including potentially life-threatening complications in 2{\%}. In the operative group (n = 56), perioperative complications occurred in 14{\%}, including potentially life-threatening complications in 7{\%}. None of the operative patients had persistent or new onset of hemangioma-associated symptoms after resection of the dominant hemangioma. In group comparison, the rate of adverse events was similar (20{\%} versus 14{\%}; p = 0.45) with an overall low risk for potentially life-threatening complications (2{\%} versus 7{\%}; p = 0.07). Size of hemangiomas was not associated with adverse events in either group. Subjective health status and quality of life at follow-up were similar in both groups (p > 0.54). Conclusions Clinical observation of patients with giant hemangioma of the liver has a similar rate of complications compared with operative management, but might prevent the need for invasive interventions in some patients. Clinical observation is preferred in most patients and operative treatment should be reserved for patients with severe symptoms or disease-associated complications.",
author = "Thomas Schnelldorfer and Ware, {Adam L.} and Rory Smoot and Schleck, {Cathy D.} and Harmsen, {William S.} and Nagorney, {David M.}",
year = "2010",
month = "12",
doi = "10.1016/j.jamcollsurg.2010.08.006",
language = "English (US)",
volume = "211",
pages = "724--730",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Management of giant hemangioma of the liver

T2 - Resection versus observation

AU - Schnelldorfer, Thomas

AU - Ware, Adam L.

AU - Smoot, Rory

AU - Schleck, Cathy D.

AU - Harmsen, William S.

AU - Nagorney, David M.

PY - 2010/12

Y1 - 2010/12

N2 - Background Management of patients with giant hemangiomas of the liver encounters persistent controversy. Although recent case series suggest a low complication rate with nonoperative management, the classic paradigm of preventive operative resection remains. Study Design A retrospective cohort study was conducted of 492 patients with giant hepatic hemangioma (>4 cm in size) diagnosed between 1985 and 2005 at Mayo Clinic Rochester. Long-term outcomes were assessed by patient survey, with a follow-up of 11 ± 6.4 years. Results Of 492 patients, 289 responded to the survey. In the nonoperative group (n = 233), 20% had persistent or new onset of hemangioma-associated symptoms, including potentially life-threatening complications in 2%. In the operative group (n = 56), perioperative complications occurred in 14%, including potentially life-threatening complications in 7%. None of the operative patients had persistent or new onset of hemangioma-associated symptoms after resection of the dominant hemangioma. In group comparison, the rate of adverse events was similar (20% versus 14%; p = 0.45) with an overall low risk for potentially life-threatening complications (2% versus 7%; p = 0.07). Size of hemangiomas was not associated with adverse events in either group. Subjective health status and quality of life at follow-up were similar in both groups (p > 0.54). Conclusions Clinical observation of patients with giant hemangioma of the liver has a similar rate of complications compared with operative management, but might prevent the need for invasive interventions in some patients. Clinical observation is preferred in most patients and operative treatment should be reserved for patients with severe symptoms or disease-associated complications.

AB - Background Management of patients with giant hemangiomas of the liver encounters persistent controversy. Although recent case series suggest a low complication rate with nonoperative management, the classic paradigm of preventive operative resection remains. Study Design A retrospective cohort study was conducted of 492 patients with giant hepatic hemangioma (>4 cm in size) diagnosed between 1985 and 2005 at Mayo Clinic Rochester. Long-term outcomes were assessed by patient survey, with a follow-up of 11 ± 6.4 years. Results Of 492 patients, 289 responded to the survey. In the nonoperative group (n = 233), 20% had persistent or new onset of hemangioma-associated symptoms, including potentially life-threatening complications in 2%. In the operative group (n = 56), perioperative complications occurred in 14%, including potentially life-threatening complications in 7%. None of the operative patients had persistent or new onset of hemangioma-associated symptoms after resection of the dominant hemangioma. In group comparison, the rate of adverse events was similar (20% versus 14%; p = 0.45) with an overall low risk for potentially life-threatening complications (2% versus 7%; p = 0.07). Size of hemangiomas was not associated with adverse events in either group. Subjective health status and quality of life at follow-up were similar in both groups (p > 0.54). Conclusions Clinical observation of patients with giant hemangioma of the liver has a similar rate of complications compared with operative management, but might prevent the need for invasive interventions in some patients. Clinical observation is preferred in most patients and operative treatment should be reserved for patients with severe symptoms or disease-associated complications.

UR - http://www.scopus.com/inward/record.url?scp=78649514099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649514099&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2010.08.006

DO - 10.1016/j.jamcollsurg.2010.08.006

M3 - Article

C2 - 20980175

AN - SCOPUS:78649514099

VL - 211

SP - 724

EP - 730

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -